B2B BUYER RESEARCH | MEDICAL-DEVICE MANUFACTURING
What evidence moves a seal-inspection system through approval?
An Evidence Acceptance Adjudication across medical-device manufacturers
THE BUSINESS DECISION A provider of sterile-barrier seal-inspection systems needed to understand how manufacturers would evaluate its evidence before allowing a pilot or validation discussion. Quality, packaging, operations, engineering, IT and procurement did not judge the same evidence in the same way. The client needed an approval route, not a generic list of product benefits.
9 MANUFACTURERS
Three production contexts
27 INTERVIEWS
Role-specific adjudication
4 EVIDENCE PACKS
Controlled review task
8 WEEKS
Example delivery window
The approval question
Is the evidence relevant, controlled and usable within the manufacturer's quality system?
Does the evidence address the actual package, seal process and inspection boundary?
Can the system fit the line, data environment, escalation process and ownership model?
Is there enough risk reduction, accountability and implementation clarity to support commitment?
Why geography remained neutral
The immediate decision concerned internal evidence acceptance and approval ownership. Manufacturers were selected by production and validation context rather than country. Geography would become an explicit parameter only where local regulatory interpretation, language, service coverage or data requirements changed the buying process.
Why interviews were required
Evidence objections are often conditional and role-specific. Individual interviews allowed participants to explain why a document was insufficient, who could resolve the gap and whether the concern would block a pilot, validation plan or purchase. A checklist survey would have recorded requirements without revealing approval consequences.
Study note: All organisations, counts and findings are hypothetical and demonstrate a possible research design, not real client outcomes.
02 | PARTICIPANTS AND EVIDENCE
Recruit people who can accept or reject the proof
Participants qualified through recent responsibility for seal inspection, packaging validation, line implementation or supplier approval.
Manufacturer cells
HIGH-VOLUME DISPOSABLES
3 manufacturers with repetitive production and high inspection throughput.
MULTI-CONFIGURATION DEVICES
3 manufacturers managing several package or product configurations.
OUTSOURCED PACKAGING STEP
3 manufacturers coordinating evidence with an external packaging or manufacturing partner.
Who reviewed the evidence
ROLE GROUP | DIRECT DECISION EXPOSURE | INTERVIEWS |
|---|---|---|
Quality and regulatory | Quality-system acceptance, validation oversight or supplier evidence review | 7 |
Packaging and engineering | Package-process knowledge, inspection requirements or technical assessment | 7 |
Operations and manufacturing | Line integration, escalation, training or production ownership | 5 |
IT, procurement and sponsors | Data, supplier approval, investment or implementation governance | 8 |
Outreach and controls
Recruitment combined independent medical-device recruiters, verified professional communities, packaging and quality networks, targeted identification and approved manufacturer contacts. Screening confirmed employer, product context, recent evidence-review responsibility and freedom from supplier conflict. Matched roles were recruited only with permission and verified separately. No participant received another role's response.
Four controlled evidence packs
PERFORMANCE
Detection claim, sample basis and operating boundary.
VALIDATION
Proposed qualification logic and manufacturer responsibilities.
INTEGRATION
Line, data, escalation and change-control concept.
SUPPLIER
Service, documentation, training and accountability model.
03 | ADJUDICATION
Evidence was accepted only when responsibility was visible
Participants assessed each pack as sufficient, conditionally sufficient or unresolved, then explained the approval consequence.
Evidence Acceptance Adjudication
1 UNAIDED STANDARD
Describe the evidence normally expected before seeing any stimulus.
2 PRIVATE REVIEW
Classify each controlled pack and annotate the missing proof.
3 CONSEQUENCE
State whether the gap blocks access, pilot, validation or purchase.
4 ROLE RECONCILIATION
Compare matched roles and assign who can resolve each gap.
Sample interview questions
RECENT APPROVAL Think about the last inspection technology that entered formal review. Which evidence gained access to the next function, and what caused delay?
PERFORMANCE PACK Which part of this performance evidence can you use as presented, and which part would need manufacturer-specific confirmation?
VALIDATION OWNERSHIP What must the supplier provide, what must your organisation generate and who approves that boundary?
LINE INTEGRATION Before operations supports a pilot, what must be clear about line impact, false calls, escalation and ownership?
PURCHASE CONDITION What unresolved evidence would stop procurement or the sponsor even if technical users supported the system?
Hypothetical evidence acceptance
ROLE GROUP | PERFORMANCE | VALIDATION | INTEGRATION | SUPPLIER |
|---|---|---|---|---|
Quality / regulatory | Conditional | Unresolved | Conditional | Conditional |
Packaging / engineering | Conditional | Conditional | Conditional | Sufficient |
Operations | Conditional | Conditional | Unresolved | Conditional |
IT / procurement / sponsor | Sufficient | Conditional | Unresolved | Conditional |
DECISION PATTERN The system did not need one larger proof deck. It needed an evidence architecture that separated supplier proof, manufacturer confirmation and accountable approval.
04 | APPROVAL APPLICATION
Move the evidence through the right owners
The output linked every evidence gap to its decision consequence and responsible owner.
Recommended approval route
ACCESS
Lead with package and process relevance, not general inspection capability.
TECHNICAL REVIEW
Separate supplier evidence from the manufacturer's confirmation work.
PILOT
Define line boundary, owners, escalation and evidence generated during the pilot.
APPROVAL
Provide a traceable package aligned to quality, operations and supplier governance.
What the client received
EVIDENCE ACCEPTANCE MATRIX Role-by-role status, missing proof and approval consequence for each evidence pack.
RESPONSIBILITY BOUNDARY MAP Evidence owned by the supplier, generated jointly or retained by the manufacturer.
PILOT ACCESS BRIEF Conditions, participants and questions required before a site pilot discussion.
APPROVAL CONVERSATION GUIDE A role-specific sequence for quality, packaging, operations, IT and procurement.
Delivery sequence
WEEK 1
Manufacturer cells and evidence-pack design.
WEEKS 2-4
Recruitment and private adjudication interviews.
WEEKS 5-7
Role reconciliation and approval architecture.
WEEK 8
Client workshop and decision-ready outputs.
STUDY BOUNDARY The research assessed buyer evidence expectations. It did not validate the inspection system, approve a sterile-barrier process or provide regulatory advice.
Contact Us
DISCUSS YOUR EVIDENCE-LED BUYING DECISION
Tell us which evidence must move through approval, which roles can accept it and where responsibility is unclear. We will design the participant and adjudication approach around that decision.